Panion & Bf Biotech Inc. (TPE:1760)
64.10
+0.10 (0.16%)
At close: Mar 24, 2026
Panion & Bf Biotech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 460.32 | 558.37 | 534.63 | 464.26 | 279.1 |
Trading Asset Securities | - | - | - | - | 69.79 |
Cash & Short-Term Investments | 460.32 | 558.37 | 534.63 | 464.26 | 348.89 |
Cash Growth | -17.56% | 4.44% | 15.16% | 33.07% | -14.12% |
Accounts Receivable | 364.86 | 366.27 | 346.96 | 354.03 | 333.9 |
Other Receivables | 57.22 | 34.42 | 11.94 | 6.68 | 29.6 |
Receivables | 422.07 | 400.7 | 358.9 | 360.71 | 363.5 |
Inventory | 568.16 | 526.93 | 538.1 | 545.65 | 528.53 |
Prepaid Expenses | 14.69 | 22.94 | 36.25 | 22.7 | 30.5 |
Other Current Assets | 1.59 | 1.52 | 8.77 | 5.97 | 3.12 |
Total Current Assets | 1,467 | 1,510 | 1,477 | 1,399 | 1,275 |
Property, Plant & Equipment | 1,693 | 1,614 | 1,635 | 1,555 | 1,521 |
Long-Term Investments | 5.75 | 33.38 | 67.54 | 75.1 | 84.03 |
Goodwill | - | 4.49 | 4.21 | 4.21 | 3.79 |
Other Intangible Assets | 14.39 | 3.56 | 7.66 | 11.76 | 15.85 |
Long-Term Deferred Tax Assets | 25.58 | 25.17 | 24.58 | 21.12 | 21.26 |
Other Long-Term Assets | 21.42 | 17.05 | 20.03 | 26.68 | 32.28 |
Total Assets | 3,227 | 3,208 | 3,235 | 3,094 | 2,953 |
Accounts Payable | 162.55 | 153.28 | 133.46 | 125.27 | 130.23 |
Accrued Expenses | - | 0.75 | 0.75 | 0.64 | 0.73 |
Short-Term Debt | 420 | 500 | 535 | 395 | 265 |
Current Portion of Long-Term Debt | - | 39.54 | 15.34 | - | 36.53 |
Current Portion of Leases | 20.23 | 11.95 | 29.87 | 29.63 | 33.19 |
Current Income Taxes Payable | 1.51 | 1.96 | 4.65 | 27.16 | 5.41 |
Other Current Liabilities | 405.48 | 319.98 | 331.78 | 343.88 | 269.41 |
Total Current Liabilities | 1,010 | 1,027 | 1,051 | 921.58 | 740.49 |
Long-Term Debt | 159.97 | 169.43 | 156.73 | 39.52 | 127.75 |
Long-Term Leases | 27.33 | 8.23 | 22.21 | 34.8 | 51.77 |
Pension & Post-Retirement Benefits | - | 2.21 | 10.5 | 11.12 | 17.48 |
Long-Term Deferred Tax Liabilities | 74.95 | 74.32 | 73.1 | 73.1 | 73.92 |
Other Long-Term Liabilities | - | 4.17 | 10.72 | 6.3 | 8.67 |
Total Liabilities | 1,272 | 1,286 | 1,324 | 1,086 | 1,020 |
Common Stock | 857.39 | 857.39 | 857.39 | 857.39 | 857.39 |
Additional Paid-In Capital | 770.86 | 806.87 | 866.89 | 871.17 | 903.76 |
Retained Earnings | 347.65 | 273.36 | 210.87 | 300.39 | 209.24 |
Comprehensive Income & Other | -21.23 | -15.44 | -24.07 | -21.84 | -37.37 |
Shareholders' Equity | 1,955 | 1,922 | 1,911 | 2,007 | 1,933 |
Total Liabilities & Equity | 3,227 | 3,208 | 3,235 | 3,094 | 2,953 |
Total Debt | 627.54 | 729.15 | 759.14 | 498.96 | 514.24 |
Net Cash (Debt) | -167.22 | -170.78 | -224.52 | -34.7 | -165.35 |
Net Cash Per Share | -1.94 | -1.99 | -2.62 | -0.40 | -2.09 |
Filing Date Shares Outstanding | 85.43 | 85.74 | 85.74 | 85.74 | 85.74 |
Total Common Shares Outstanding | 85.43 | 85.74 | 85.74 | 85.74 | 85.74 |
Working Capital | 457.05 | 482.99 | 425.79 | 477.71 | 534.04 |
Book Value Per Share | 22.88 | 22.42 | 22.29 | 23.41 | 22.55 |
Tangible Book Value | 1,940 | 1,914 | 1,899 | 1,991 | 1,913 |
Tangible Book Value Per Share | 22.71 | 22.32 | 22.15 | 23.22 | 22.32 |
Land | - | 784.44 | 784.44 | 784.44 | 798.98 |
Buildings | - | 401.62 | 396.32 | 335.79 | 375.78 |
Machinery | - | 867.21 | 858.1 | 834.7 | 1,102 |
Construction In Progress | - | 217.31 | 150.96 | 105.74 | 81.46 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.